EDGAR Filing Documents for 0001104659-23-072266

Form 8-K - Current report:

SEC Accession No. 0001104659-23-072266

Filing Date

2023-06-16

Accepted

2023-06-16 16:23:40

Documents

Period of Report

2023-06-13

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm239563d1_8k.htm iXBRL	8-K	45428
2	EXHIBIT 4.1	tm239563d1_ex4-1.htm	EX-4.1	114821
3	EXHIBIT 10.1	tm239563d1_ex10-1.htm	EX-10.1	57806
4	EXHIBIT 99.1	tm239563d1_ex99-1.htm	EX-99.1	10435
	Complete submission text file	0001104659-23-072266.txt		455809

Data Files

Seq	Description	Document	Type	Size
5	XBRL TAXONOMY EXTENSION SCHEMA	fwbi-20230613.xsd	EX-101.SCH	3045
6	XBRL TAXONOMY EXTENSION LABEL LINKBASE	fwbi-20230613_lab.xml	EX-101.LAB	34476
7	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	fwbi-20230613_pre.xml	EX-101.PRE	22603
9	EXTRACTED XBRL INSTANCE DOCUMENT	tm239563d1_8k_htm.xml	XML	3608

Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431

Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020

First Wave BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)